Davis Jerel

This profile gathers the share dealings of Davis Jerel across 4 companies, led by Chinook Therapeutics, Inc., Repare Therapeutics Inc. and Turnstone Biologics Corp. Between 5 May 2021 and 8 August 2025, the trades on record add up to 24 filings.

Sales make up the whole of the open-market record (6 sales, €31.9M). Other entries cover 1 option exercise.

On 8 August 2025 came the latest disclosure, a transaction in Turnstone Biologics Corp. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.